These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 35223684)
1. Risk Factors of Young-Onset Colorectal Cancer: Analysis of a Large Population-Based Registry. Danial D; Youssef ED; Maryam BM; Mohammad A; Moein BM; Liliane D Can J Gastroenterol Hepatol; 2022; 2022():3582443. PubMed ID: 35223684 [TBL] [Abstract][Full Text] [Related]
2. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008). Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511 [TBL] [Abstract][Full Text] [Related]
5. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey. Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504 [TBL] [Abstract][Full Text] [Related]
6. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea. Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241 [TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? Dyson JK; Rutter MD World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036 [TBL] [Abstract][Full Text] [Related]
8. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah. Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782 [TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer in inflammatory bowel disease: review of the evidence. Keller DS; Windsor A; Cohen R; Chand M Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345 [TBL] [Abstract][Full Text] [Related]
10. Colorectal Cancer associated with pediatric inflammatory bowel disease: a case series. Kim MJ; Ko JS; Shin M; Hahn JW; Moon SY; Kim HY; Moon JS BMC Pediatr; 2021 Nov; 21(1):504. PubMed ID: 34763671 [TBL] [Abstract][Full Text] [Related]
11. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study. Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402 [TBL] [Abstract][Full Text] [Related]
12. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792 [TBL] [Abstract][Full Text] [Related]
13. Family History Associates With Increased Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Samadder NJ; Valentine JF; Guthery S; Singh H; Bernstein CN; Leighton JA; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Burt RW; Curtin K; Smith KR Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1807-1813.e1. PubMed ID: 30267862 [TBL] [Abstract][Full Text] [Related]
15. Association of inflammatory bowel disease in first-degree relatives with risk of colorectal cancer: A nationwide case-control study in Sweden. Wang K; Olén O; Emilsson L; Khalili H; Halfvarson J; Song M; Ludvigsson JF Int J Cancer; 2023 Jun; 152(11):2303-2313. PubMed ID: 36760205 [TBL] [Abstract][Full Text] [Related]
16. Has the risk of colorectal cancer in inflammatory bowel disease decreased? Andersen NN; Jess T World J Gastroenterol; 2013 Nov; 19(43):7561-8. PubMed ID: 24282346 [TBL] [Abstract][Full Text] [Related]
17. Is inflammatory bowel disease an important risk factor among older persons with colorectal cancer in the United States? A population-based case-control study. Shaukat A; Virnig DJ; Salfiti NI; Howard DH; Sitaraman SV; Liff JM Dig Dis Sci; 2011 Aug; 56(8):2378-83. PubMed ID: 21409378 [TBL] [Abstract][Full Text] [Related]
18. Rates and characteristics of postcolonoscopy colorectal cancer in the Swedish IBD population: what are the differences from a non-IBD population? Stjärngrim J; Ekbom A; Hammar U; Hultcrantz R; Forsberg AM Gut; 2019 Sep; 68(9):1588-1596. PubMed ID: 30554159 [TBL] [Abstract][Full Text] [Related]
19. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study. Bernstein CN; Nugent Z; Blanchard JF Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180 [TBL] [Abstract][Full Text] [Related]
20. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study. Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788 [No Abstract] [Full Text] [Related] [Next] [New Search]